Antonio Yelamos-Martinez

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Serum biomarkers remain stable after transitioning from intravenous to subcutaneous natalizumab in multiple sclerosis.

Serum biomarkers remain stable after transitioning from intravenous to subcutaneous natalizumab in multiple sclerosis.

Journal: Journal of neurology

Published: April 28, 2026

Proteomic profile of CSF obtained at the time of diagnosis determines amyotrophic lateral sclerosis progression and survival: CXCL7 levels in disease prognosis and survival.

Proteomic profile of CSF obtained at the time of diagnosis determines amyotrophic lateral sclerosis progression and survival: CXCL7 levels in disease prognosis and survival.

Journal: Brain pathology (Zurich, Switzerland)

Published: August 12, 2025

The 2024 McDonald criteria show comparable sensitivity to previous criteria for late-onset multiple sclerosis.

The 2024 McDonald criteria show comparable sensitivity to previous criteria for late-onset multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: June 26, 2025

3D T1 turbo spin echo improves detection of gadolinium-enhancing multiple-sclerosis lesions.

3D T1 turbo spin echo improves detection of gadolinium-enhancing multiple-sclerosis lesions.

Journal: Insights into imaging

Published: May 29, 2025

Benign multiple sclerosis and long-term outcomes after 30 years.

Benign multiple sclerosis and long-term outcomes after 30 years.

Journal: Journal of neurology

Published: May 28, 2025

Posterior Reversible Encephalopathy Syndrome as a Complication of Essential Thrombocythemia: A Case Report and Literature Review.

Posterior Reversible Encephalopathy Syndrome as a Complication of Essential Thrombocythemia: A Case Report and Literature Review.

Journal: Cureus

Published: April 18, 2025

Post-contrast Susceptibility Weighted Imaging in Multiple Sclerosis MRI Improves the Detection of Enhancing Lesions.

Post-contrast Susceptibility Weighted Imaging in Multiple Sclerosis MRI Improves the Detection of Enhancing Lesions.

Journal: Clinical neuroradiology

Published: October 22, 2024

Is antiparasitic treatment beneficial in chronic subarachnoid neurocysticercosis? A comparative case series.

Is antiparasitic treatment beneficial in chronic subarachnoid neurocysticercosis? A comparative case series.

Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)

Published: October 13, 2024

Assessment of the Multiple Sclerosis Severity Score and the Age-Related Multiple Sclerosis Severity Score as health indicators in a population-based cohort.

Assessment of the Multiple Sclerosis Severity Score and the Age-Related Multiple Sclerosis Severity Score as health indicators in a population-based cohort.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: July 24, 2024

Increased CXCL12, a potential CSF biomarker for differential diagnosis of amyotrophic lateral sclerosis.

Increased CXCL12, a potential CSF biomarker for differential diagnosis of amyotrophic lateral sclerosis.

Journal: Brain communications

Published: February 21, 2024

The T1-dark-rim: A novel imaging sign for detecting smoldering inflammation in multiple sclerosis.

The T1-dark-rim: A novel imaging sign for detecting smoldering inflammation in multiple sclerosis.

Journal: European journal of radiology

Published: December 27, 2023

Baseline serum neurofilament light chain levels differentiate aggressive from benign forms of relapsing-remitting multiple sclerosis: a 20-year follow-up cohort.

Baseline serum neurofilament light chain levels differentiate aggressive from benign forms of relapsing-remitting multiple sclerosis: a 20-year follow-up cohort.

Journal: Journal of neurology

Published: October 08, 2023

Showing 1-12 of 24

Last Updated: 09/26/2026